Draxxin is a drug owned by ZOETIS INC. It is protected by 7 US drug patents filed from 2018 to 2021. All patents have expired. Details of Draxxin’s patents and their expiration are given below.
Exclusivity Information
Draxxin holds 1 exclusivity out of which 1 has expired. Details of Draxxin's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Oct 16, 2017 |
About Draxxin
Draxxin is a drug
owned by ZOETIS INC.
Draxxin uses
Tulathromycin as the active
ingredient.
Active Ingredient:
Draxxin uses
Tulathromycin as the active ingredient.
Check out other Drugs and Companies using
Tulathromycin ingredient.